134 Chapter 5 protein influences pregnenolone production in lymphomonocytes of healthy individuals. Endocrinology. Dec 2009;150(12):5438-45. doi:10.1210/en.2009-0752 130. Prossin AR, et al. Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorder. Psychoneuroendocrinology. Mar 2018;89:194-202. doi:10.1016/j. psyneuen.2018.01.013 131. Fan J, et al. Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med. May 2012;12(4):369-86. doi:10.2174/1566524011207040369 132. Yeliseev AA, et al. A sensory transducer homologous to the mammalian peripheral-type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J Biol Chem. Sep 8 1995;270(36):21167-75. doi:10.1074/jbc.270.36.21167 133. Yeliseev AA, et al. A mammalian mitochondrial drug receptor functions as a bacterial “oxygen” sensor. Proc Natl Acad Sci U S A. May 13 1997;94(10):51016. doi:10.1073/pnas.94.10.5101 134. Fan J, et al. Translocator protein 2 is involved in cholesterol redistribution during erythropoiesis. J Biol Chem. Oct 30 2009;284(44):30484-97. doi:10.1074/jbc.M109.029876 135. Betlazar C, et al. Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain. Int J Mol Sci. Sep 11 2018;19(9)doi:10.3390/ijms19092707 136. Lavisse S, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci. Aug 8 2012;32(32):10809-18. doi:10.1523/ JNEUROSCI.1487-12.2012 137. Pannell M, et al. Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia. Sep 3 2019;doi:10.1002/glia.23716 138. Pulagam KR, et al. Evaluation of the novel TSPO radiotracer [(18)F] VUIIS1008 in a preclinical model of cerebral ischemia in rats. EJNMMI Res. Nov 25 2017;7(1):93. doi:10.1186/s13550-017-0343-7 139. Rojas S, et al. Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. Dec 2007;27(12):1975-86. doi:10.1038/ sj.jcbfm.9600500 140. Li HD, et al. A translocator protein 18 kDa agonist protects against cerebral ischemia/reperfusion injury. J Neuroinflammation. Jul 28 2017;14(1):151. doi:10.1186/s12974-017-0921-7 141. Banati RB, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain. Nov 2000;123 ( Pt 11):2321-37. doi:10.1093/brain/123.11.2321 142. Daugherty DJ, et al. A TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol Med. Jun 2013;5(6):891-903. doi:10.1002/ emmm.201202124 143. Daugherty DJ, et al. The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis. Sci Rep. Mar 1 2016;6:22556. doi:10.1038/srep22556 144.Nack A, et al. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells. Jan 28 2019;8(2)doi:10.3390/ cells8020094 145. Zinnhardt B, et al. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [(18)F]DPA-714 PET and MRI. Theranostics. 2019;9(6):1523-1537. doi:10.7150/thno.32461 146. Ji B, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses inmouse models of Alzheimer’s and other CNS pathologies. J Neurosci. Nov 19 2008;28(47):12255-67. doi:10.1523/ JNEUROSCI.2312-08.2008 147. Esquerda-Canals G, et al. Mouse Models of Alzheimer’s Disease. J Alzheimers Dis. 2017;57(4):1171-1183. doi:10.3233/JAD-170045 148. Liu B, et al. In Vivo Detection of Age- and DiseaseRelated Increases in Neuroinflammation by 18FGE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer’s Transgenic Mice. J Neurosci. Nov 25 2015;35(47):15716-30. doi:10.1523/ JNEUROSCI.0996-15.2015 149. Sacher C, et al. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second Generation Amyloid-beta Mouse Model. J Nucl Med. Jul 13 2019;doi:10.2967/jnumed.119.227322 150. Tournier BB, et al. TSPO and amyloid deposits in subregions of the hippocampus in the 3xTgAD mouse model of Alzheimer’s disease. Neurobiol Dis. Jan 2019;121:95-105. doi:10.1016/j.nbd.2018.09.022 151.Mirzaei N, et al. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer’s disease. Glia. Jun 2016;64(6):993-1006. doi:10.1002/glia.22978 152.Notter T, et al. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry. Jan 17 2017;doi:10.1038/mp.2016.248 153. Gong J, et al. Translocator Protein Ligand Protects against Neurodegeneration in the MPTP Mouse Model of Parkinsonism. J Neurosci. May 8 2019;39(19):3752-3769. doi:10.1523/ JNEUROSCI.2070-18.2019 154. Pannell M, et al. Imaging of translocator protein upregulation is selective for pro-inflammatory polarized astrocytes and microglia. Glia. Feb 2020;68(2):280-297. doi:10.1002/glia.23716
RkJQdWJsaXNoZXIy MTk4NDMw